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Abstract
Background: Community distribution of anti-malarials and antibiotics has been recommended as a strategy to
reduce the under-five mortality due to febrile illnesses in sub-Saharan Africa. However, drugs distributed in these
interventions have been considered weak by some caretakers and utilization of community medicine distributors
has been low. The aim of the study was to explore caretakers' use of drugs, perceptions of drug efficacy and
preferred providers for febrile children in order to make suggestions for community management of pneumonia
and malaria.
Methods: The study was conducted in eastern Uganda using four focus group discussions with fathers and
mothers of children under five; and eight key informant interviews with health workers in government and non-
governmental organization facilities, community medicine distributors, and attendants in drug shops and private
clinics. Caretakers were asked the drugs they use for treatment of fever, why they considered them efficacious,
and the providers they go to and why they go there. Health providers were interviewed on their opinions of
caretakers' perceptions of drugs and providers. Analysis was done using content analysis.
Results:  Drugs that have been phased out as first-line treatment for malaria, such as chloroquine and
sulphadoxine/pyrimethamine, are still perceived as efficacious. Use of drugs depended on perception of the
disease, cost and drug availability. There were divergent views about drug efficacy concerning drug combinations,
side effects, packaging, or using drugs over time. Bitter taste and high cost signified high efficacy for anti-malarials.
Government facilities were preferred for conducting diagnostic investigations and attending to serious illnesses,
but often lacked drugs and did not treat people fast. Drug shops were preferred for having a variety of drugs,
attending to clients promptly and offering treatment on credit. However, drug shops were considered
disadvantageous since they lacked diagnostic capability and had unqualified providers.
Conclusion: Community views about drug efficacy are divergent and some may divert caretakers from obtaining
efficacious drugs for febrile illness. Interventions should address these perceptions, equip community medicine
distributors with capacity to do diagnostic investigations and provide a constant supply of drugs. Subsidized
efficacious drugs could be made available in the private sector.
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Background
Febrile illnesses like malaria and pneumonia are major
contributors to the high child mortality rates in sub-Saha-
ran Africa [1]. Various countries committed themselves to
reduce child mortality rates by two thirds by 2015 [2]. The
distribution of anti-malarials and antibiotics at commu-
nity level by community medicine distributors (CMDs)
[3,4] is one of the interventions recommended to reduce
mortality from febrile illnesses. This strategy has been
shown to reduce morbidity in Burkina Faso [5] under five
mortality due to malaria in Ethiopia [6] and mortality due
to pneumonia in Nepal [7]. A meta-analysis of commu-
nity case management of pneumonia in India, Pakistan,
Bangladesh, Philippines and Tanzania showed a mortality
reduction of 27% [8,9]. The momentum of introducing
community case management of pneumonia is high in
Africa [10] and national programmes for community
health workers are being planned in Ethiopia, India,
Kenya, Uganda and South Africa [11].
However, drugs distributed by CMDs have been perceived
by some caretakers as weak [12] or ineffective [13]. Com-
munity management of febrile illnesses has used pre-
packed drugs [14], but some women in western Uganda
did not like pre-packed drugs [15]. New drugs are to be
distributed, which are different from the previous ones.
Caretakers trusted in the efficacy of chloroquine as an
anti-malarial due to its bitter taste [16]. Artemether/lume-
fantrine (AL), the new first-line treatment of malaria is not
bitter. Cotrimoxazole is the first-line of treatment for
pneumonia in Uganda, but a high in vitro resistance has
been reported [17]. Amoxicillin is the second drug of
choice. Studies differ on caretaker use of antibiotics with
some showing high utilization [18] and others showing
that antibiotics are not cited in the treatment for fever
[19]. Much of the community management of pneumo-
nia has been in Asia and few studies have taken place in
sub-Saharan Africa. Even in the presence of CMDs, some
caretakers prefer to go to drug shops and private clinics
[12]. Utilization of CMDs was noted to be low where the
community distribution of anti-malarials was done in
Democratic Republic of Congo [20], The Gambia [21],
Uganda [14] and Kenya [22].
If the community distribution of anti-malarials and anti-
biotics is to have an impact on child mortality, it needs to
be used by a big proportion of the febrile children. The
strategy needs to offer drugs that are seen by caretakers as
efficacious. The CMDs need to be seen as providers that
would manage malaria and pneumonia. The aim of the
study was to explore caretakers' use of drugs, perceptions
of drug efficacy and preferred providers and make sugges-
tions for the distribution of anti-malarials and antibiotics
at community level.
Methods
Study area
The study was done in Iganga district in eastern Uganda,
located about 115 km from the capital Kampala. The dis-
trict population is about 661,400 (2008 estimate).
Malaria is endemic in the area and the under five mortal-
ity rate for the region is 128/1,000 live births [23]. The
majority of the population are Basoga who speak Lusoga
and are mostly engaged in subsistence farming. The area
is served by 58 government and 23 non-governmental
organization (NGO) health facilities. Many of the govern-
ment facilities frequently lack drugs. There are 110 regis-
tered drug shops and 36 registered private clinics,
especially in trading centres, which sell analgesics, such as
paracetamol (Panadol®) and aspirin, anti-malarials, such
as chloroquine, sulphadoxine/pyrimethamine (SP)(Fan-
sidar®) and quinine, and antibiotics, such as cotrimoxa-
zole and amoxicillin. Like in many other parts of the
country, many of the drug shops and private clinics are
not registered [24,25]. Artemether/lumefantrine
(AL)(Coartem®) is currently distributed through govern-
ment and NGO health facilities and its distribution by
CMDs has not yet been implemented [26]. There was no
community distribution of anti-malarials and antibiotics
at the time of the study. However, before the change of
first-line anti-malarials from chloroquine and SP to AL,
there were 960 trained and functional CMDs in the dis-
trict. They used to distribute chloroquine and SP free-of-
charge to under five children at community level. Since AL
is very expensive on the open market, most drug shops
and private clinics in the rural areas did not stock it [27].
There were also traditional healers scattered in the vil-
lages.
Study population and data collection techniques
The data collection methods included focus group discus-
sions (FGDs) and key informant interviews (KIIs). Four
FGDs were conducted: two with fathers and another two
with mothers. Each FGD was conducted in a different sub-
county. Two of the FGDs were in sub-counties close to
and another two in sub-counties far away from the district
headquarters. Whereas most fevers are managed at clinics
and drug shops by mothers, FGDs of fathers were con-
ducted because fathers also play a significant role in the
health care seeking of febrile children, especially when
costs are to be incurred. All FGD participants had children
below five years and were known residents of the area.
They were mobilized by a community member identified
by the research group. They were considered 'information
rich cases' [28], as they were in a good position to discuss
experiences about childhood illnesses. Each FGD had
between nine and 12 participants. FGDs were conducted
in one of the homes of the FGD participants.Malaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
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FGDs were used to generate debate and allow the partici-
pants explore their views and opinions about drugs and
their efficacy and preferences for providers [29]. By having
fathers and mothers alone, the FGDs gave a chance to
mothers, who may not have expressed themselves freely
in the presence of men, to do so. FGDs give an opportu-
nity for the researchers to listen to people who have little
chance of expressing their opinions [30]. Both the inter-
viewer and the note taker were social scientists and expe-
rienced in conducting FGDs. They spoke both English and
the local language fluently. The first FGD, which was with
women, was attended by ER and XN. Afterwards, ER, XN
and KK went through the notes. They discussed with the
interviewer and the note taker their experiences of the
emerging issues and whether questions were being under-
stood. An efficacious drug was described as one which was
powerful hence able to cure the disease and a non-effica-
cious drug as that which was weak and would not be able
to cure the disease when used. The FGDs were conducted
using an FGD guide which focused on drugs that caretak-
ers give children with fever or fever and cough, the drugs
they consider efficacious, those they consider non-effica-
cious and why. Other questions focussed on which pro-
viders caretakers go to when the children present with
fever and why they go to such providers.
Eight KIIs were conducted by an experienced social worker
fluent in both English and the local language. Two of the
KIIs were held with health workers from two of the local
health facilities (one being government and another
NGO), two with attendants in drug shops, two with
attendants in private clinics and two with people who had
been functioning as community medicine distributors
before. The six respondents from the drug shops, private
clinics and public health facilities were: two clinical offic-
ers, two nurses, one mid wife and one nursing assistant.
Each came from a different health facility, drug shop or
clinic. Those interviewed as former CMDs were the com-
munity members who had functioned as CMDs, when
chloroquine and SP were still being distributed free at
community level. By the time of the interview, they were
not actively distributing any drug within the community.
Respondents in KIIs were chosen because they would have
interacted closely with caretakers of febrile children. Key
informant interviews were conducted to capture the expe-
riences of the providers as they do interface with the care-
takers when the latter come for health care. Four KI
interviews were conducted first and then data reviewed by
ER and XN to assess how the questions were being
answered before the other four interviews were done. The
guiding questions for the KIIs included identification of
the drugs, which the caretakers used for malaria and for
pneumonia, which of the drugs caretakers considered effi-
cacious and why. Other questions focussed on health pro-
viders to whom caretakers went to when their children
were febrile and why they preferred such providers.
The research assistants were trained by the investigators
on how to use the tools. The data was collected in July –
August 2008. All the data were tape recorded and tran-
scribed. The FGDs were conducted in the local language,
transcribed and later translated into English by the inter-
viewers. The researchers listened to the tapes to confirm
the information.
Data analysis
Content analysis was used [31]. The unit of analysis was
the transcripts from FGDs and KIIs. The authors read
through the data and discussed, sometimes coming up
with different issues and debating on them and eventually
came up with codes. After the first discussion, ER, XN and
KK went back and read through the material again after
which they met and generated more codes, which were
discussed and agreed upon. These codes were merged into
categories and then into themes.
Ethical clearance
The study was approved by Makerere University School of
Public Health Institutional Review Board and the Uganda
National Council of Science and Technology (HS 72). Per-
mission to carry out the study was received from the local
leaders. Verbal informed consent was received from all the
participants.
Results
There were four key findings of the study: (1) Quite often
respondents were not up-to-date with the newly recom-
mended drugs as some of them said they were still using
chloroquine and/or SP for fever. They also tended to mix
anti-malarials and antibiotics as belonging to one cate-
gory. Drugs used for fever that were commonly men-
tioned included analgesics, anti-malarials, antibiotics,
anticonvulsants, steroids and traditional medicines. (2)
Caretakers gave divergent views about efficacy of different
drug combinations, packaged drugs and significance of
side effects. (3) Both private and public health providers
were used for treating febrile illness, each in specific cir-
cumstances. (4) The ideal provider was that who had diag-
nostic capability, was nearby, available all the time and
provided a constant supply of a variety of drugs.
Caretakers' use of drugs
Drugs used by caretakers to treat febrile children included
analgesics, such as Panadol®, diclofenac® and ibuprofen;
anti-malarials, such as chloroquine, Fansidar®, quinine
and Coartem®. Other drugs included diazepam, dexame-
thasone and traditional herbs like "lubirizi"(Vernonia
amygdalina)  and "akabombo akaganda" (CyphostemmaMalaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
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adenocaule). Chloroquine and Panadol® were the com-
monest drugs cited for treating fever. For treating cough,
the majority mentioned septrin (cotrimoxazole). Other
drugs included chloramphenicol syrup, ampicillin syrup,
PPF (procaine penicillin) and herbs, like aloevera (Aloe
vera chinensis) and lemon leaves. Majority of the partici-
pants indicated that they would give a sick child drugs
they would either already have at home or getting them
from a drug shop. Care from health facilities would be
sought when the child would not improve. Traditional
medicine for treating fever was known by the caretakers
themselves and they did not need to get it from a tradi-
tional healer.
Some of the drugs considered weak were used as first aid
and more powerful ones as last resort. Drugs perceived to
be weak included chloroquine, Fansidar®, Panadol®,
diclofenac and septrin. However, there were some of the
respondents who perceived these drugs to be efficacious
and were using them to treat children. According to the
majority of the caretakers, even weak drugs had an impor-
tant role to play.
For me what I know is that there is no treatment, which
does not work because it only depends on the severity of the
fever. (FGD women)
Quinine was considered powerful and often used as last
resort.
For us we know that we first begin with a weak drug and
advance to powerful drugs as the sickness worsens. Quinine
is given last when the other drugs have failed. (FGD Men)
This was in agreement with opinions of providers on care-
takers:
Parents consider chloroquine a weak drug but they also
think that if the child has slight malaria, chloroquine can
be adequate and can help the person to get cured. (KI
former CMD)
Use of drugs was also influenced by how much money
one could spend and presence of the drug on the market.
Capsules are very expensive so I rather settle for the tablets
like septrin because one capsule costs 100/= and for 100/=
you get 8 septrin tablets." (FGD women)
Sometimes money is also a determinant. The child can be
four months and you advise the caretaker to use quinine
syrup but the caretaker will tell you that she has very little
money so you give them chloroquine tablets. (KI Drug
shop attendant)
Most caretakers say septrin is weak yet we have it on open
market.... we have to buy septrin tablets and give them to
the patients because they are on open market. (KI clinic
attendant)
Caretakers' perception of drug efficacy
Views on drug efficacy were diverse and there were often
disagreements on which drug is efficacious when com-
bined with others, what side effects show about drug effi-
cacy, packaging, what prompt recovery shows about the
drug taken and efficacy of using a drug for some time.
Taste and cost as indicators of efficacy were discussed
though without much disagreement.
The majority of the participants argued that drugs are
effective when given in combinations. They maintained
that there are some drugs which cannot work unless they
are combined with others. Some participants thought
Panadol® was best because it is given with other drugs, like
Fansidar®. Some other participants perceived a drug like
Panadol®, which is usually added onto other drugs, as
weak.
There were many considerations that made people con-
clude that a drug was efficacious. Such considerations
included side effects, packaging, the drug source, how
quickly the body responded to the drug. There was no
consensus on the implications of a drug having side
effects. For some, it was a sign of a drug being strong.
For me, the drug that cures very well is quinine. Even when
you take quinine you can feel it. It is very strong because you
even feel pain in the ears after taking it. (FGD Men)
Sometimes if they give a drug to a child and he/she weakens
then they say the drug is strong. (KI drug shop attendant)
While others argued that when a drug has no side effects,
it is a sign that the drug is efficacious and appropriate for
the disease in question.
Once the drug is given to the child and does not involve any
complications like convulsions, vomiting or shivering, then
I know that the drug is recommended for malaria and I
know that that drug works. (FGD Men)
There were also diverse views on packaging with some say-
ing that pre-packaged drugs were the ones which were effi-
cacious.
Those drugs that are not in the blister pack are the ones that
are most likely to be duplicated. Me I prefer the ones in the
blister seal. (FGD Men)Malaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
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However, there were others who on the contrary argued
that since the government health facilities usually had the
tablets that are not packed; those in blister packs were
fake.
I think that the drugs in the blister seal are not as original
as the other common ones (loose ones) because even govern-
ment has the loose ones which they keep in the tins, so I
think that the ones in the tins are the original ones and
those in blister packs are fake.(FGD men).
Drugs that had immediate effect on the condition of the
child were considered by some of the respondents as effi-
cacious. Other participants argued to the contrary and
said that no drug cures immediately.
There is no medicine that cures immediately, they all work
gradually because diseases come quickly but go slowly.
(FGD women)
There were disagreements as to what happens when a per-
son has used a drug for some time. Some held the view
that when a person uses a drug for some time, the drug
would no longer cure that particular person.
On my side, quinine works well on my child but these days
when I use it, the fever resumes after some time. ... May be
the child's body has gotten used to quinine and the child's
body is not responding hence quinine cannot treat the fever
any more. (FGD women)
Experience with the use of some of the drugs influenced
the way people perceived the drugs.. It was common for
people to refer to the drugs they use often as being less
efficacious. Other participants had dissenting views sug-
gesting that people are cured by certain drugs which they
have gotten used to.
Some people use chloroquine injections but they fail to get
cured from the fever because they are used to another type
of treatment. For instance I may use chloroquine injections
and I do not get cured and yet when I use fansidar tablets,
I get cured. (FGD women)
A summary of divergences in perceptions of drug efficacy
is shown in Table 1.
Most of the participants were of the opinion that having a
bitter taste was a sign of a drug being efficacious for the
treatment of malaria. In addition, a big section of the FGD
participants held the view that expensive drugs were more
efficacious than the cheap ones.
I think that all drugs that cure malaria should be bitter...
this is because malaria is strong and therefore needs some
mixture that is equally bitter. Me, if I tested a medicine for
malaria that's not bitter, I would know that it is just a fake
one and I would not accept it, I can't purchase it. (FGD
Men)
For us here, if there is any medicine that's cheap, we suspect
that where as it is used to treat malaria, it may not work
well. We believe that certain drugs are expensive because
they work. For example when you buy 10 chloroquine tab-
lets, a dose may be only 200/= while a dose of only 3 fan-
sidar tablets is at 1500/=. So fansidar is seen as being more
powerful (FGD Men)
Preference for providers
Both private and public providers were used for managing
febrile illness. However, the preferences were for provid-
ers: where there was no waiting, open all the time, which
were nearby, could give treatment on credit, had drugs,
and had diagnostic capability.
The majority of the participants credited drug shops for
being able to give treatment promptly unlike government
facilities, which do not even give special attention to very
sick children.
Table 1: Divergences in perceptions of drug efficacy
Description One opinion Another divergent opinion
1. When using drugs in combination A powerful drug is found in drug combinations A weak drug is the one in drug combinations
2. Drugs having side effects This is a sign that a drug is efficacious This is a sign that a drug is not efficacious
3. Pre-packaged drugs Are the ones which are efficacious Are not efficacious, they are fake
4. Drugs giving fast recovery from the illness Shows that the drug is efficacious There is no drug that gives quick recovery. All 
drugs act slowly
5. Effect of using a drug for some time Makes the person be cured by preferably that 
drug
Makes a person unable to be cured by that drugMalaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
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Unlike government facilities, private clinics and drug shops
care about their clients. Once you reach there, you are wel-
comed nicely and served immediately, but at the govern-
ment health facility you can enter at 9:00 am and the
doctor may or may not attend to you at 1:00 pm, so in cases
where you need immediate attention you have no option but
to go to the private clinic or drug shop.(FGD Men)
When you go to the main hospital you make a line even
when the child is in poor condition and the child may die
before being attended to. (FGD women)
Drug shops were also commended by most of the
respondents for being near and being able to give services
even at night unlike the government facilities that were
far.
For us when get sick from malaria we get treatment through
buying these drugs from the drug shops because even our
government facility is very far away from here. For example
a child can fall sick at night so I have to get the treatment
from the drug shop other than go at night to the government
facility. (FGD women)
The drug shops have a range of drugs on the shelves and can
give you the quantities you want, they can mix for you the
drugs according to your money, they are also near us and
since we are the same customers, they can give you treat-
ment on credit and may even bargain for a cheaper cost.
(FGD Men)
When you go to Nakavule (the general hospital in the dis-
trict), you need to use a motor cycle yet if you have 500/=
you can go to the nearby drug shop and get drugs (KI
former CMD)
However, drug shops and private clinics had drawbacks.
Few of the FGD participants said that these private provid-
ers sometimes used nursing assistants without enough
qualifications. The caretakers would still to go to them
because of having no other choice. Drug shops did not do
laboratory investigations and hence were perceived to
treat the children basing on symptoms. To some partici-
pants, this was tantamount to guesswork.
I can get medicine like chloroquine from the drug shops
although the nursing assistant who is there does not have
enough qualifications but I have no option but to go to
them. (FGD Women)
Now here we have a problem when a child is sick, the drug
shop attendants just start on treatment without checking
the child's blood to see what is in the blood to see the dis-
ease. When you take the child to the drug shop, they just put
it on treatment. (FGD women)
Some caretakers were of the opinion that government
facilities had the new and efficacious drug against malaria
(Coartem®). When children needed intravenous fluids or
blood, they had to be taken to the government hospital.
They also had capacity to do laboratory investigations.
This was also reflected in a comment from a former CMD
who praised services at government facilities because
there was proper diagnostic equipment;
Government facilities are good because if one falls sick they
are advised to go to a health facility so that they can have a
blood checkup. When my child fell sick, I was advised to
take the child to the hospital for a blood test so that she can
receive the appropriate treatment. (KI former CMD)
Table 2 summarizes preferred provider attributes.
Discussion
Drugs which caretakers consider 'weak' are still being used
sometimes as a form of 'first aid' and sometimes as treat-
ment. Caretakers' perceptions on drug efficacy are not
consistent and include diverse considerations on efficacy
of drugs used in combinations, significance of side effects,
efficacy of pre-packed drugs and significance of prompt
recovery. Caretakers' ideal providers are those who offer
investigations and have a variety of drugs. Whereas gov-
ernment facilities are preferred for being able to conduct
diagnostic investigations and handling serious illnesses,
they are often short of drugs. Drug shops are the ones that
can supply constantly a variety of drugs, offer treatment
promptly and have convenient opening hours.
Caretakers more often use weak drugs in treating febrile
children. Chloroquine and paracetamol are the common-
est treatment for fever. There is much resistance to chloro-
quine and SP [32]. This means that people use drugs
which are less efficacious. As efficacy of a drug declines,
children would not improve on drugs that they previously
improved on. Drugs that were distributed by CMDs at first
were chloroquine and SP [12] but with time, their efficacy
went down. This sheds more light on why drugs from
CMDs were considered weak [12-14]. However, caretakers
still use these drugs. The Uganda Demographic and
Health survey recorded a high utilization of chloroquine
and SP for treating febrile children [33]. Non-efficacious
drugs could be used because they are cheap or because the
efficacious ones are not in the drug shops in the rural areas
[27]. Previous studies have demonstrated that it is feasible
to distribute efficacious drugs with CMDs [34] and drug
shops [35]. Although drug shops have been associated
with promptness of treatment for febrile children
[36]they are not providing the recommended drugs as per
the new treatment guidelines. This continued use of non-
efficacious anti-malarials brings challenges to effective
treatment of malaria.Malaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
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The study findings indicate that the perceptions about
drugs, which are efficacious cannot be generalized. There
were differences in opinion about drugs, which come in
combinations, the significance of side effects, drug pack-
aging and implications of time of symptom clearance.
Most caretakers agreed that drug combinations are effica-
cious. This could have been a product of policy by com-
bining chloroquine and SP or artemether and
lumefantrine. There has also been occasions of poly phar-
macy in drug utilization in Africa just because of the "pill
for every ill" [37,38]. In the "pill for every ill" concept, a
patient with multiple symptoms like hot body, headache,
dizziness and joint pains, all of which may be symptoms
of malaria, could be treated with one pill for hot body,
another for headache, another for dizziness and even with
another for joint pains instead of the one pill anti-malar-
ial. Other studies have reported that CMDs were not uti-
lized because of lack of the combination aspect-they only
provided one drug [12]. Not many studies have high-
lighted side effects as influencing perceptions about drug
efficacy. Despite previous history of community manage-
ment of fever [14], there are still disagreements on efficacy
of packaged drugs. Seeking quick recovery could partly
explain the popularity of analgesics and chloroquine,
which also has antipyretic properties. Based on these find-
ings it is still difficult to point out the drugs that are per-
ceived to be efficacious generally. It is important to note
that whenever a drug works for caretakers, the drug is effi-
cacious and there is general tendency to think that some
drugs work for some children and not others [12]. Some
of these perceptions like associating efficacy with drugs
that are not pre-packaged may divert caretakers from
obtaining pre-packaged drugs from CMDs and need to be
addressed in interventions.
In this study, a common belief was that people may get
used to a drug, which means that the drug cannot be used
to cure them next time. Conversely, other participants
argued that only drugs that the body has gotten used to
can cure the illness. This could be a community way of
explaining drug failure, stemming from the common care-
taker use of drugs with reduced efficacy in treating
malaria. There has been an increase in malaria parasite
resistance to chloroquine and SP [39,40]. The first-line
treatment for malaria has been changed to AL. Different
scenarios could explain this drug failure. It is possible that
caretakers use drugs like chloroquine and SP that have
reduced efficacy because they are still on the open market.
It is also possible that the caretakers give a wrong medi-
cine like an anti-malarial drug to a child with pneumonia
and say that the drug is less efficacious [19]. The emic con-
cepts – cultural constructs of efficacy – often differ from
the etic explanations – concepts with scientific explana-
tion [41]. While biomedical efficacy would be tagged to
clearance of malarial parasites in blood, caretakers would
be satisfied with lowering of body temperature or as indi-
cated by some, presence of side effects like noise in the
ears after taking quinine. Another possibility could be that
the caretakers have not yet adopted the new first line drug
for malaria treatment. Communities have been shown to
Table 2: Preferred provider attributes
Attribute Government facility Private clinic or drug shop Comments
1. Attend to clients fast No Yes Some times one waits at government facilities 
and does not get treatment
2. Can attend to the child any time of 
day or night
No Yes At night it is difficult to go to government 
facilities because they are far
3. Are nearby No Yes Sometimes the cost of transport is more than 
the cost of treatment
4. Have drugs in constant supply No Yes Drug shops do not have the new anti-malarials 
of Coartem®
5. Can conduct investigations Yes No Investigations are needed to find out why 
previous treatment did not work
6. Have qualified workers Yes No Drug shops have unqualified workers but 
there is no choice, caretakers have to use 
them
7. Handle complicated illnesses Yes No Without the lab, there is need for 
investigations and drug shops do not have that 
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be slow to take on new policies as demonstrated in Tanza-
nia [42]. It becomes more problematic when the drug
shops where the caretakers seek treatment first do not
have first line treatment for malaria [27]. Drug shops pro-
vide drugs in respect for consumer preferences and the cli-
ent's ability to pay for the drugs. They often do not
consider the symptoms but rather what the person
requests. Because people do not have a clear understand-
ing of the right drugs for fever, they often ask for wrong
drugs and sometimes take under dose, which they can
afford. Efficacious drugs remain outside the reach of the
majority when drugs are difficult to obtain from outside
the government health facilities [43].
Community interventions could build on the preference
of caretakers for drug shops because the latter offered a
constant supply of drugs, treated clients promptly, gave
treatment on credit, and were nearby. This has influenced
caretakers to choose them for care [44,45]. Some of the
challenges levelled against the home based management
of fevers have been frequent stock outs of drugs at the
CMDs [46]. Frequent stock outs will drive caretakers to
drug shops who don't stock the first-line anti-malarials
(artemether/lumefantrine) [27].
Caretakers prefer government facilities when children
have more serious symptoms because the government
facilities are able to conduct laboratory investigations.
When caretakers take children for treatment outside the
home, they want to know the cause of the illness that is
not responding to treatment. The acceptance of CMDs
could potentially increase if they were equipped with
diagnostic tests such as rapid diagnostic tests (RDTs) for
malaria. RDTs have been promoted in situations where
there are no laboratories for microscopy [47] and are
being used to identify cases of malaria at community level
so as not to give artemether/lumefantrine, an expensive
anti-malarial, to any child with fever [48]. Drug shops
have been shown to offer poor quality [25,49]. However,
febrile children would benefit if multifaceted interven-
tions including training, supervision, and regulation were
extended to drug shops and private clinics [50].
Methodological considerations
Using different methods and respondents, and having
researchers from different backgrounds from social sci-
ence, medicine and the basic sciences was aimed at getting
an objective perspective of the data. The study was faced
with the challenge of the limitations of the qualitative
methods, which do not give the magnitude across the dif-
ferent categories of the respondents. However triangula-
tion of information across caretakers and health
providers, across mothers and fathers, using both FGDs
and KIIs, was very useful in checking consistency and con-
tradictions both across and within groups [51,52]. The use
of purposively selected participants makes the research
findings not generalizable to the general population.
Another limitation is that the study reports the caretakers'
stated use of drugs rather than actual practices. However,
separating women from men in the FGDs and asking
questions focussed on common health care-seeking prac-
tices could have promoted free expression of the partici-
pants and also reduced answers given to please the
researcher. Further studies will be needed to address the
impact of these caretakers' perceptions on the actual care
that the febrile children receive.
Conclusion and recommendations
Caretakers sometimes use what they perceive as 'weak'
drugs as 'first aid' and if the child does not get well, go for
more powerful drugs. This aggravates the problem of drug
resistance and misuse. There are divergent views among
caretakers on what factors imply that a drug is efficacious.
Some perceptions may divert caretakers from using pre-
packaged drugs from CMDs. As caretakers would prefer to
get the drugs from providers that have diagnostic ability,
attend to clients fast, and are available all the time,
nearby, trained and have a constant supply of efficacious
drugs, there is great potential for community distribution
of anti-malarials and antibiotics to meet community
expectations if CMDs live up to these standards. To
increase the success of the home management of fever
strategy, there is need to develop strategies for constant
drug supply, to sensitize caretakers on which drugs are
currently efficacious, and to avail subsidized efficacious
drugs also in the private sector.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ER, XN, GP, GT, SP and KK took part in designing the
study, in tools development, in data analysis and in man-
uscript writing. ER, XN and KK did field work. All authors
approved the final manuscript.
Acknowledgements
This study received financial support from Sida/SAREC – Makerere Univer-
sity – Karolinska Institutet research collaboration and from UNICEF/
UNDP/World Bank/WHO Special Program for Research and Training in 
Tropical Diseases. Its contents are solely the responsibility of the authors 
and do not reflect the views of Sida/SAREC nor UNICEF/UNDP/World 
Bank/WHO Special Program for Research and Training in Tropical Dis-
eases nor the authors' institutions of affiliation. The study participants, 
research assistants, Iganga/Mayuge Demographic Surveillance Site, Iganga 
and Mayuge districts, WHO/Uganda and Ministry of Health Uganda are all 
acknowledged for their support and contribution.
References
1. Black RE, Morris SS, Bryce J: Where and why are 10 million chil-
dren dying every year?  Lancet 2003, 361:2226-2234.Malaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
Page 9 of 10
(page number not for citation purposes)
2. United Nations Secretariat: The Millenium Development Goals Report
New York: United Nations Department of Economic and Social
Affairs; 2006. 
3. WHO/UNICEF: WHO/UNICEF joint statement: Management
of pneumonia in community settings.  Geneva 2004.
4. Winch PJ, Gilroy KE, Wolfheim C, Starbuck ES, Young MW, Walker
LD, Black RE: Intervention models for the management of
children with signs of pneumonia or malaria by community
health workers.  Health Policy Plan 2005, 20:199-212.
5. Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, Pagnoni F:
Early treatment of childhood fevers with pre-packaged anti-
malarial drugs in the home reduces severe malaria morbid-
ity in Burkina Faso.  Trop Med Int Health 2003, 8:133-139.
6. Kidane G, Morrow RH: Teaching mothers to provide home
treatment of malaria in Tigray, Ethiopia: a randomised trial.
Lancet 2000, 356:550-555.
7. Dawson P, Pradhan Y, Houston R, Karki S, Poudel D, Hodgins S:
From research to national expansion: 20 years' experience of
community-based management of childhood pneumonia in
Nepal.  Bull World Health Organ 2008, 86:339-343.
8. Rasmussen Z, Pio A, Enarson P: Case management of childhood
pneumonia in developing countries: recent relevant
research and current initiatives.  Int J Tuberc Lung Dis 2000,
4:807-826.
9. Sazawal S, Black RE: Effect of pneumonia case management on
mortality in neonates, infants, and preschool children: a
meta-analysis of community-based trials.  Lancet Infect Dis 2003,
3:547-556.
10. Marsh DR, Gilroy KE, Weerdt R Van de, Wansi E, Qazi S: Commu-
nity case management of pneumonia: at a tipping point?  Bull
World Health Organ 2008, 86:381-389.
11. Haines A, Sanders D, Lehmann U, Rowe AK, Lawn JE, Jan S, Walker
DG, Bhutta Z: Achieving child survival goals: potential contri-
bution of community health workers.  Lancet 2007,
369:2121-2131.
12. Nsabagasani X, Jesca Nsungwa S, Kallander K, Peterson S, Pariyo G,
Tomson G: Home-based management of fever in rural
Uganda: community perceptions and provider opinions.
Malar J 2007, 6:11.
13. Malimbo M, Mugisha E, Kato F, Karamagi C, Talisuna AO: Caregiv-
ers' perceived treatment failure in home-based manage-
ment of fever among Ugandan children aged less than five
years.  Malar J 2006, 5:124.
14. Nsungwa-Sabiiti J, Peterson S, Pariyo G, Ogwal-Okeng J, Petzold MG,
Tomson G: Home-based management of fever and malaria
treatment practices in Uganda.  Trans R Soc Trop Med Hyg 2007,
101:1199-1207.
15. Kilian AH, Tindyebwa D, Gulck T, Byamukama W, Rubaale T, Kabag-
ambe G, Korte R: Attitude of women in western Uganda
towards pre-packed, unit-dosed malaria treatment for chil-
dren.  Trop Med Int Health 2003, 8:431-438.
16. Tarimo DS, Minjas JN, Bygbjerg IC: Perception of chloroquine
efficacy and alternative treatments for uncomplicated
malaria in children in a holoendemic area of Tanzania: impli-
cations for the change of treatment policy.  Trop Med Int Health
2001, 6:992-997.
17. Joloba ML, Bajaksouzian S, Palavecino E, Whalen C, Jacobs MR: High
prevalence of carriage of antibiotic-resistant Streptococcus
pneumoniae in children in Kampala Uganda.  Int J Antimicrob
Agents 2001, 17:395-400.
18. Denno DM, Bentsi-Enchill A, Mock CN, Adelson JW: Maternal
knowledge, attitude and practices regarding childhood acute
respiratory infections in Kumasi, Ghana.  Ann Trop Paediatr
1994, 14:293-301.
19. Hildenwall H, Rutebemberwa E, Nsabagasani X, Pariyo G, Tomson G,
Peterson S: Local illness concepts–implications for manage-
ment of childhood pneumonia in eastern Uganda.  Acta Trop
2007, 101:217-224.
20. Delacollette C, Stuyft P Van der, Molima K: Using community
health workers for malaria control: experience in Zaire.  Bull
World Health Organ 1996, 74:423-430.
21. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P,
Hayes RJ, N'Jie AB: Comparison of two strategies for control of
malaria within a primary health care programme in the
Gambia.  Lancet 1988, 1:1121-1127.
22. Spencer HC, Kaseje DC, Collins WE, Shehata MG, Turner A, Stanfill
PS, Huong AY, Roberts JM, Villinski M, Koech DK: Community-
based malaria control in Saradidi, Kenya: description of the
programme and impact on parasitaemia rates and antima-
larial antibodies.  Ann Trop Med Parasitol 1987, 81(Suppl 1):13-23.
23. Uganda Bureau of Statistics and ORC Macro: Uganda Demo-
graphic and Health Survey 2006.  Calverton, Maryland, USA:
UBOS and ORC Macro; 2007. 
24. Government of Uganda: Utilizing the potential of formal and informal pri-
vate practitioners in child survival in Uganda: situation analysis and outline
for developing a national strategy Kampala: Ministry of Health; 2001. 
25. Tawfik Y, Nsungwa-Sabitii J, Greer G, Owor J, Kesande R, Prysor-
Jones S: Negotiating improved case management of child-
hood illness with formal and informal private practitioners in
Uganda.  Trop Med Int Health 2006, 11:967-973.
26. Rutebemberwa E, Pariyo G, Peterson S, Tomson G, Kallander K: Uti-
lization of public or private health care providers by febrile
children after user fee removal in Uganda.  Malar J 2009, 8:45.
27. Medicines for Malaria Venture, Ministry of Health (Uganda), HEPS,
WHO: Understanding the Antimalarials Market: Uganda 007
– an overview of the supply side.  Medicines for Malaria Venture;
2008. 
28. Patton MQ: Qualitative Research & Evaluation Methods.  3rd
edition. London: Sage Publications; 2002. 
29. Dahlgren L, Emmelin M, Winkvist A: Qualitative Methodology for
International Public Health.  Umea: Umea University; 2004. 
30. Rice PL, Ezzy D: Qualitative Research Methods – A Health Focus Oxford,
New York: Oxford University Press; 1999. 
31. Graneheim UH, Lundman B: Qualitative content analysis in
nursing research: concepts, procedures and measures to
achieve trustworthiness.  Nurse Educ Today 2004, 24:105-112.
32. Kamya MR, Bakyaita NN, Talisuna AO, Were WM, Staedke SG:
Increasing antimalarial drug resistance in Uganda and revi-
sion of the national drug policy.  Trop Med Int Health 2002,
7:1031-1041.
33. Uganda Bureau of Statistics (UBOS) and ORC Macro: Uganda
Demographic and Health Survey 2006.  Calverton, Maryland,
USA: UBOS and ORC Macro; 2007. 
34. Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, Agyei-Baf-
four P, Doamekpor L, Balyeku A, Munguti K, Cousens S, et al.: Feasi-
bility and acceptability of artemisinin-based combination
therapy for the home management of malaria in four Afri-
can sites.  Malar J 2008, 7:6.
35. Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh
K:  Improving malaria home treatment by training drug
retailers in rural Kenya.  Trop Med Int Health 2004, 9:451-460.
36. Rutebemberwa E, Kallander K, Tomson G, Peterson S, Pariyo G:
Determinants of delay in care-seeking for febrile children in
eastern Uganda.  Trop Med Int Health 2009, 14:472-479.
37. Adome RO, Whyte SR, Hardon A: Popular pills: community drug
use in Uganda.  Amsterdam: Het Spinhuis; 1996. 
38. Whyte SR: Questioning misfortune.  Cambridge: Cambridge Uni-
versity Press; 1997. 
39. Talisuna AO, Okello PE, Erhart A, Coosemans M, D'Alessandro U:
Intensity of malaria transmission and the spread of Plasmo-
dium falciparum resistant malaria: a review of epidemiologic
field evidence.  Am J Trop Med Hyg 2007, 77(6 Suppl):170-180.
40. Sendagire H, Kaddumukasa M, Ndagire D, Aguttu C, Nassejje M, Pet-
tersson M, Swedberg G, Kironde F: Rapid increase in resistance
of Plasmodium falciparum to chloroquine-Fansidar in Uganda
and the potential of amodiaquine-Fansidar as a better alter-
native.  Acta Trop 2005, 95:172-182.
41. Etkin N: Cultural Constructions of Efficacy.  In The Context of
Medicines in Developing Countries Edited by: Van der Geest S, Whyte
SR. Amsterdam: Het Spinhuis Publishers; 1991. 
42. Eriksen J, Nsimba SE, Minzi OM, Sanga AJ, Petzold M, Gustafsson LL,
Warsame MY, Tomson G: Adoption of the new antimalarial
drug policy in Tanzania–a cross-sectional study in the com-
munity.  Trop Med Int Health 2005, 10:1038-1046.
43. Baume C, Helitzer D, Kachur SP: Patterns of care for childhood
malaria in Zambia.  Soc Sci Med 2000, 51:1491-1503.
44. Deressa W, Ali A, Hailemariam D: Malaria-related health-seek-
ing behaviour and challenges for care providers in rural Ethi-
opia: implications for control.  J Biosoc Sci 2008, 40:115-135.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2009, 8:131 http://www.malariajournal.com/content/8/1/131
Page 10 of 10
(page number not for citation purposes)
45. Nyamongo IK: Health care switching behaviour of malaria
patients in a Kenyan rural community.  Soc Sci Med 2002,
54:377-386.
46. Fapohunda BM, Plowman Beth Ann, Azairwe Robert, Bisoborwa
Geoffrey, Langi Peter, Kato Fredrick, Wang Xiaotian: Home Based
Management of Fever Strategy in Uganda: A Report of the
2003 Survey.  Arlington, Virginia, USA: MOH, WHO and BASICS II;
2004. 
47. Kyabayinze DJ, Tibenderana JK, Odong GW, Rwakimari JB, Counihan
H: Operational accuracy and comparative persistent anti-
genicity of HRP2 rapid diagnostic tests for Plasmodium falci-
parum malaria in a hyperendemic region of Uganda.  Malar J
2008, 7:221.
48. Harvey SA, Jennings L, Chinyama M, Masaninga F, Mulholland K, Bell
DR:  Improving community health worker use of malaria
rapid diagnostic tests in Zambia: package instructions, job
aid and job aid-plus-training.  Malar J 2008, 7:160.
49. Zwi AB, Brugha R, Smith E: Private health care in developing
countries.  BMJ 2001, 323:463-464.
50. Mills A, Brugha R, Hanson K, McPake B: Approaches for improv-
ing service delivery in the non state sector: what is the evi-
dence on what works, where and why?  Making Services Work
for the Poor: World Development Report 2003/04 Workshop, Eyn-
sham, Oxfordshire; 2002. 
51. Berg BL: Qualitative Research Methods for Social Sciences.
Needham Heights: Allyn and Bacon; 2001. 
52. Flick U: Triangulation Revisited: Strategy of Validation or
Alternative?  Journal for the Theory of Social Behaviour 1992,
22:175-197.